Browse Items (2 total)
Sort by:
Tags: 0 (Antioxidants), 2005, 2208-40-4 (6-sulfatoxymelatonin), Administration Oral, Adolescent, Antioxidants, Antioxidants/ad [Administration & Dosage], Antioxidants/pk [Pharmacokinetics], Case-Control Studies, characteristics, Child, Child Preschool, Circadian Rhythm, English J, Female, Hancock E, Humans, JL5DK93RCL (Melatonin), Journal of Child Neurology, Male, melatonin, Melatonin/aa [Analogs & Derivatives], Melatonin/ad [Administration & Dosage], Melatonin/pk [Pharmacokinetics], Melatonin/ur [Urine], O'Callaghan F, Osborne J P, Reference Values, sleep disturbance/disorders, Sleep Wake Disorders, Sleep Wake Disorders/co [Complications], Sleep Wake Disorders/pp [Physiopathology], Trajectory, Tuberous Sclerosis, Tuberous Sclerosis/co [Complications], Tuberous Sclerosis/pp [Physiopathology]
Tags: 2013, Angelman Syndrome/co [Complications], Angelman Syndrome/dt [Drug Therapy], Anticonvulsants/ad [Administration & Dosage], Anticonvulsants/ae [Adverse Effects], Anticonvulsants/tu [Therapeutic Use], Backlog, Epilepsies, Faulkner MA, Humans, Journal Article, KT Synthesis, Myoclonic/co [Complications], Myoclonic/dt [Drug Therapy], Pharmacotherapy, Rett Syndrome/co [Complications], Rett Syndrome/dt [Drug Therapy], Seizures/co [Complications], Seizures/dt [Drug Therapy], Singh Sanjay P, Treatment Outcome, Tuberous Sclerosis/co [Complications], Tuberous Sclerosis/dt [Drug Therapy]